Daniel Barber joined Aquestive in July 2007. Prior to joining Aquestive, Mr. Barber held various positions with Quest Diagnostics in their corporate planning and international divisions. Over the last ten years Mr. Barber has been instrumental in the growth of Aquestive Therapeutics. In 2010, Mr. Barber had executive oversight of the company’s launch activities for Aquestive’s first two FDA approved products. In 2013, Mr. Barber helped lead the company’s effort to develop an internal pipeline of proprietary assets. Since that time he has had executive responsibility for Aquestive’s pipeline and partnership activities. Mr. Barber received his BA degree from State University of New York at Geneseo and an MBA from Seton Hall University.